Pharmacological management of anxiety in patients suffering from schizophrenia;Prise en charge médicamenteuse de l'anxiété chez le patient souffrant de schizophrénie

Encephale

Volumn 37, Issue SUPPL. 1, 2011, Pages

  Bayle F J ^a   Blanc, O ^b   De Chazeron, I ^b   Lesturgeon, J ^c   Lanon, C ^d   Caci, H ^e   Garay, R P ^f,g   Llorca, P M ^b  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c Centre Médico psychothérapique Sainte Marie   (France)

^d HÔPITAL SAINTE MARGUERITE   (France)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^f Universite Paris Sud   (France)

^g NONE   (France)

Author keywords

Anxiety; Scale; Schizophrenia; Treatment

Indexed keywords

CYAMEMAZINE;

AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; CLINICAL EFFECTIVENESS; DYSPHORIA; GENERALIZED ANXIETY DISORDER; HUMAN; MENTAL PATIENT; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; SCHIZOPHRENIA; SOCIAL PHOBIA; TRANQUILIZING ACTIVITY;

EID: 79956205445     PISSN: 00137006     EISSN: 00137006     Source Type: Journal    
DOI: 10.1016/j.encep.2010.08.009     Document Type: Short Survey

References (49)

1. J.F. Allilaire Angoisse psychotique et angoisse névrotique. Différence qualitative ou différence quantitative ? L'Encéphale 9 Suppl. 2 1983 211B 216B (Pubitemid 14128036)
2. APA. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia, 2nd edition. www.apa.org ; 2004.
3. D. Bailly, M. Viellard, and H. Duverger Un diagnostic méconnu : la schizophrénie chez l'enfant Ann Med Psychol 161 2003 652 659 (Pubitemid 37516703)
4. T.R.E. Barnes Pharmacological strategies for relapse prevention in schizophrenia Psychiatry 3 2004 37 40
5. F.J. Baylé, M.O. Krebs, and C. Epelbaum Clinical features of panic attacks in schizophrenia Eur Psychiatry 16 2001 349 353 (Pubitemid 32928949)
6. F.J. Baylé, P.M. Llorca, and J.P. Olié Anxié té et schizophrénie : situation actuelle Ann Med Psychol 158 2000 741 749
7. I. Berman, B.L. Sapers, and H.H. Chang Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine J Clin Psychopharmacol 15 1995 206 210
8. P.C. Bermanzohn, L. Porto, and P.B. Arlow At issue: hierarchical diagnosis in chronic schizophrenia: a clinical study of co-occurring syndromes Schizophr Bull 26 2000 517 525
9. O. Blanc Validation of a new anxiety scale in schizophrenia (EAS scale) Schizophr Res 102 2008 224 1224
10. J.J. Blanchard, K.T. Muser, and A.S. Bellack Anhedonia, positive and negative affect and social functioning in schizophrenia Schizophr Bull 24 1998 413 424 (Pubitemid 28378226)
11. R.C. Bland, S.C. Newman, and H. Orn Schizophrenia: lifetime comorbidity in a community sample Acta Psychiatr Scand 75 1987 383 391 (Pubitemid 17063974)
12. O. Blin, J.M. Azorin, and P. Bouhours Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients J Clin Psychopharmacol 16 1996 38 44
13. O. Blin, J.M. Azorin, and Y. Lecrubier Psychotic Anxiety Scale (PAS) : évaluation de la fidélité intercotateurs et analyse factorielle des correspondances L'Encéphale 15 1989 543 547
14. M. Bourin, E. Dailly, and M. Hascöet Preclinical and clinical pharmacology of cyamemazine: anxiolytic effects and prevention of alcohol and benzodiazepine withdrawal syndrome CNS Drug Rev 10 2004 219 229 (Pubitemid 39403052)
15. R.J. Braga, M.V. Mendlowicz, and R.P. Marrocos Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life J Psychiatric Res 39 2005 409 414 (Pubitemid 40404090)
16. R.J. Braga, G. Petrides, and I. Figueira Anxiety disorders in schizophrenia Comp Psychiatry 45 2004 460 468 (Pubitemid 39446811)
17. P.F. Buckley Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials Curr Med Res Opinion 20 2004 1357 1363 (Pubitemid 39361338)
18. C.Y. Chen, C.Y. Liu, and Y.Y. Yang Correlation of panic attacks and hostility in chronic schizophrenia Psychiatry Clin Neurosci 55 2001 383 387
19. S.J. Cosoff, and R.J. Hafner The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder Aust N Z J Psychiatry 32 1998 67 72 (Pubitemid 28163919)
20. J.L. Cutler, and S.G. Siris "Panic-like" symptomatology in schizophrenic and schizoaffective patients with post-psychotic depression: observations and implications Comp Psychiatry 32 1991 465 473
21. L.W. Davis, A.M. Strasburger, and L.F. Brown Mindfulness: an intervention for anxiety in schizophrenia J Psychosoc Nurs Ment Health Serv 45 2007 23 29
22. M. Dossenbach, M. Jakovljevicz, and V. Folnegovic Olanzapine versus fluphenazine - 6 weeks treatment of anxiety symptoms during acute schizophrenia Schizophr Res 29 1998 203 1203
23. R.A. Emsley, P.P. Oosthuizen, and A.F. Joubert Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder J Clin Psychiatry 60 1999 747 751
24. R. Gaillard, A. Ouanas, and C. Spadone Benzodiazépines et schizophrénie, revue de la littérature L'Encéphale 32 2006 1003 1010
25. M. Garvey, R. Noyes, and D. Anderson Examination of comorbid anxiety in psychiatric inpatients Comp Psychiatry 32 1991 277 282
26. C. Gury, C. Fabre, and A. Hameg Prescription d'antipsychotiques en milieu hospitalier spécialisé Inf Psychiatr 82 2006 1 7
27. J.D. Huppert, and T.E. Smith Longitudinal analysis of subjective quality of life in schizophrenia: anxiety as the best symptom predictor J Nerv Ment Dis 189 2001 669 675 (Pubitemid 32979828)
28. J.D. Huppert, and T.E. Smith Anxiety and schizophrenia: the interaction of subtypes of anxiety and psychotic symptoms CNS Spectr 10 2005 721 731 (Pubitemid 41443047)
29. J.D. Huppert, K.A. Weiss, and R. Lim Quality of life in schizophrenia: contributions of anxiety and depression Schizophr Res 51 2001 171 180 (Pubitemid 32772850)
30. S. Kasper Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia Depress Anxiety 20 2004 44 47 (Pubitemid 39331963)
31. K.S. Kendler, T.J. Gallagher, and J.M. Abelson Lifetime prevalence, demographic risk factors, and diagnostic validity of non-affective psychosis as assessed in a US community sample. The National Comorbidity Survey Arch Gen Psychiatry 53 1996 1022 1031 (Pubitemid 26384671)
32. M.S. Keshavan, V.A. Diwadkar, and D.M. Montrose Premorbid indicators and risk for schizophrenia: a selective review and update Schizophr Res 79 2005 45 57 (Pubitemid 41363765)
33. C. Lanon, V. Aghababian, and P.M. Llorca Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five-dimensional factor analysis Acta Psychiatr Scand 97 1998 369 376 (Pubitemid 28529681)
34. P.M. Llorca La schizophrénie M. Leboyer, P.L. Morselli, Encyclopédie Orphanet 2004 Inserm Paris, France
35. Lôo H. L'anxiété dans les psychoses. In: Lebois-Offset, editor. L'anxiété. Bar sur Aube; 1977, p. 41-57.
36. P.H. Lysaker, and J. Hammersley Association of delusions and lack of cognitive flexibility with social anxiety in schizophrenia spectrum disorders Schizophr Res 86 2006 147 153 (Pubitemid 44234051)
37. N. Muller Mechanisms of relapse prevention in schizophrenia Pharmacopsychiatry 37 Suppl. 2 2004 S141 S147
38. R.M. Norman, A.K. Malla, and L. Cortese Aspects of dysphoria and symptoms of schizophrenia Psychol Med 28 1998 1433 1441 (Pubitemid 28521608)
39. K.H. Nuechterlein, M. Dawson, and J. Ventura The vulnerability/stress model of schizophrenic relapse: a longitudinal study Acta Psychiatr Scand 382 Suppl. 1994 58 64 (Pubitemid 24199715)
40. P. Nuss, P.M. Llorca, and C. Lanon Activité anxiolytique de la cyamémazine : rôle des récepteurs sérotoninergiques Inf Psychiatr 83 2007 595 601
41. S. Pallanti, L. Quercioli, and E. Hollander Social anxiety in outpatients with schizophrenia: a relevant cause of disability Am J Psychiatry 161 2004 53 58 (Pubitemid 38419307)
42. M. Poyurovsky, C. Fuchs, and A. Weizman Obsessive-compulsive disorder in patients with first-episode schizophrenia Am J Psychiatry 156 1999 1998 2000
43. F. Radat Cyamémazine : traitement symptomatique des dimensions anxieuses, impulsives et agressives Inf Psychiatr 10 1995 967 968
44. I. Reznik, and P. Sirota Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics J Clin Psychopharmacol 20 2000 410 416 (Pubitemid 30463756)
45. J.L. Romain, P. Dermain, and P. Greslé Efficacité de l'acétate de zuclopenthixol sur l'anxiété psychotique évaluée lors d'une étude ouverte L'Encéphale 22 1996 280 286 (Pubitemid 26364061)
46. M. Sannomiya, H. Katsu, and K. Nakayama A clinical study of emergent anxiety in neuroleptic-naïve, first-episode schizophrenia patients following treatment with risperidone Seishin Shinkeigaku Zasshi 105 2003 643 658
47. S. Sevy, K. Nathanson, and H. Visweswaraiah The relationship between insight and symptoms in schizophrenia Compr Psychiatry 45 2004 16 19 (Pubitemid 38029970)
48. P. Tibbo, J. Swainson, and P. Chue Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia Depress Anxiety 17 2003 65 72 (Pubitemid 36407100)
49. L. White, P.D. Harvey, and L. Opler Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale Psychopathology 30 1997 263 274